Clinical Trial Update: Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares two acellular dermal matrices, SurgiMend PRS and AlloDerm RTU, for tissue expander breast reconstruction in breast cancer pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AlloDerm RTU
• SurgiMend PRS

Snippet

Sponsor: University of Pittsburgh | Conditions: Breast Cancer, Mastectomy | Phase 4 | Status: COMPLETED | Results posted: 2017-05-12